Dexmethylphenidate HCl 20 mg 24HR Extended Release Oral Capsule
RxNorm 899485
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 899485 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dexmethylphenidate HCl 20 mg 24HR Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
24 HR dexmethylphenidate hydrochloride 20 mg Extended Release Oral Capsule
(Atom ID: 6349115)
PSNPrescribable
Prescribable Name (PSN):
Dexmethylphenidate HCl 20 mg 24HR Extended Release Oral Capsule
(Atom ID: 6367030)
SYPrescribable
Synonym (SY):
Dexmethylphenidate hydrochloride 20 mg 24 HR Extended Release Oral Capsule
(Atom ID: 6354363)
PTPrescribable
Designated preferred name (PT):
Dexmethylphenidate hydrochloride 20 mg prolonged-release oral capsule
(Atom ID: 11436356)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely dexmethylphenidate hydrochloride 20 mg/1 each prolonged-release oral capsule (clinical drug)
(Atom ID: 11439691)
Patient Education
Dexmethylphenidate
Dexmethylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children. Dexmethylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by increasing the amounts of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.